SPOTLIGHT -
Emerging Biopharma Tackles the Opioid Crisis
Dr. Steven Fox, CEO of Akelos Inc., discusses the challenges of developing new non-opioid medical products as the need intensifies as the crisis worsens.
FDA’s John Whyte Delves Deeper into Patient Centricity
The FDA’s Dr. John Whyte offers his perspectives on patient centricity and the issues that FDA and industry are facing.
Will Another Recession Bash the Biopharmaceutical Industry?
Amidst arguments that industry is heading for another economic recession, Moe Alsumidaie reminds us that biopharma has shown resiliency during such times.
Income and Depression: A Predictive Model for Clinical Trials Patient Dropout
Moe Alsumidaie looks at data collection methods and concepts that can result in predicting patients at risk of dropping out from a clinical trial.
Clinical Ops: Highlights From this Year's SCOPE Summit
The clinical trial technological landscape continues to morph, as we are starting to see the emergence of novel technologies and techniques to enhance clinical trial strategies and productivity.
Enhancing Racial Diversity in Clinical Trials
The report analyzed data from several biopharmaceutical and medical device clinical trials, and emphasized several observations